Clinical trial

Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)

NCT01026831

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-01-06

PhasePHASE3

Study timeline

Study start (actual)2010-01-06Date precision: day

Registry last updated2017-06-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Open-angle Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

Preservative-Free TafluprostDRUG

Comparator: timololDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01026831 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.